About N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide
N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide (PubChem CID 71115180) has the molecular formula C33H33F3N6O2
and a molecular weight of 602.66 g/mol. Its IUPAC name is N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide.
Molecular Properties
| Compound Name | N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide |
| PubChem CID | 71115180 |
| Molecular Formula | C33H33F3N6O2 |
| Molecular Weight | 602.66 g/mol |
| Exact Mass | 602.26 |
| IUPAC Name | N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide |
| SMILES | Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1-c1ccc2cc(NC(=O)C3CC3)ncc2c1 |
| InChI | InChI=1S/C33H33F3N6O2/c1-20-28(23-6-5-22-15-30(38-17-26(22)13-23)40-31(43)21-3-4-21)16-27(18-37-20)39-32(44)24-7-8-25(29(14-24)33(34,35)36)19-42-11-9-41(2)10-12-42/h5-8,13-18,21H,3-4,9-12,19H2,1-2H3,(H,39,44)(H,38,40,43) |
| InChIKey | RGUHHMPVBDARCD-UHFFFAOYSA-N |
| XLogP | 5.97 |
| TPSA | 90.46 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 602.66 |
| LogP ≤ 5 | 5.97 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide?
The IUPAC name of N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide (CID 71115180) is N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide.
What is the SMILES notation for N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide?
The canonical SMILES for N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide is Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1-c1ccc2cc(NC(=O)C3CC3)ncc2c1.
What is the InChIKey of N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide?
The InChIKey is RGUHHMPVBDARCD-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H33F3N6O2/c1-20-28(23-6-5-22-15-30(38-17-26(22)13-23)40-31(43)21-3-4-21)16-27(18-37-20)39-32(44)24-7-8-25(29(14-24)33(34,35)36)19-42-11-9-41(2)10-12-42/h5-8,13-18,21H,3-4,9-12,19H2,1-2H3,(H,39,44)(H,38,40,43).
What are the key properties of N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide?
N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide has a molecular weight of 602.66 g/mol, XLogP of 5.97, 7 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[3-(cyclopropanecarbonylamino)isoquinolin-7-yl]-6-methyl-3-pyridinyl]-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzamide is sourced from PubChem (CID 71115180), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).